This section contains the medicaid agency's rules for the endorsing practitioner therapeutic interchange program (TIP). TIP is established under RCW
69.41.190 and
70.14.050.
(1) TIP applies only to drugs:
(a) Within therapeutic classes on the Washington preferred drug list (Washington PDL);
(b) Included in a motion passed by the pharmacy and therapeutics (P&T) committee; and
(c) Prescribed by an endorsing practitioner.
(2) TIP does not apply to a drug when:
(a) The P&T committee determines that TIP does not apply to the drug or its therapeutic class on the Washington PDL;
(b) Prescribed by a nonendorsing practitioner;
(c) The endorsing practitioner signs the prescription "dispense as written (DAW)"; or
(d) Otherwise prohibited under RCW
69.41.190.
(3) The agency may impose nonendorsing status on an endorsing practitioner only under the circumstances outlined in RCW
69.41.190.
(4) Except as otherwise provided in subsection (5) of this section, the agency may restrict a client's first course of treatment within a therapeutic class, according to the provisions in RCW
69.41.190.
(5) In accordance with WAC
182-530-4125(3) and
182-501-0165, the agency will request and review the endorsing practitioner's medical justification for preferred and nonpreferred brand name drugs and nonpreferred generic drugs for the client's first course of treatment.
[Statutory Authority: RCW
41.05.021 and
41.05.160. WSR 17-07-001, § 182-530-4150, filed 3/1/17, effective 4/1/17; WSR 16-01-046, § 182-530-4150, filed 12/9/15, effective 1/9/16. WSR 11-14-075, recodified as § 182-530-4150, filed 6/30/11, effective 7/1/11. Statutory Authority: RCW
74.04.050,
74.09.700,
74.08.090, 2009 c 575. WSR 10-06-011, § 388-530-4150, filed 2/19/10, effective 3/22/10. Statutory Authority: RCW
74.04.050,
74.08.090,
74.09.700, 2008 c 245. WSR 08-21-107, § 388-530-4150, filed 10/16/08, effective 11/16/08. Statutory Authority: RCW
74.04.050,
74.08.090,
74.09.530, and
74.09.700. WSR 07-20-049, § 388-530-4150, filed 9/26/07, effective 11/1/07.]